Literature DB >> 19629995

Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic rats.

Krisztina L Malisza1, Cheryl Jones, Marco L H Gruwel, Derek Foreman, Paul Fernyhough, Nigel A Calcutt.   

Abstract

PURPOSE: To determine if differences exist between control and diabetic rats in functional magnetic resonance imaging (fMRI) activity of the spinal cord and if fMRI can provide a means of early detection of diabetic neuropathy.
MATERIALS AND METHODS: fMRI of the spinal cord, using noxious electrical stimulation (15 V ( approximately 8 mA), 0.3 msec, 3 Hz) of the hind paw, was performed in groups of control and streptozotocin (STZ)-induced type 1 diabetic rats.
RESULTS: Diabetic rats were lighter, hyperglycemic, and had lower blood pH than controls. fMRI activity at the lumbar enlargement of the spinal cord was identified in the dorsal horn ipsilateral to stimulus of all animals. Signal intensity changes across the lumbar spinal cord during periods of activity were not significantly different between control and diabetic rats, with a trend toward greater signal changes in controls. When specific regions of the spinal cord were analyzed, control rats exhibited significantly increased blood-oxygen level-dependent (BOLD) fMRI activity in both ipsilateral and contralateral dorsal horn compared to diabetic rats.
CONCLUSION: The results of this study are consistent with reports that primary afferent input to the spinal cord is diminished by diabetes, and suggest that BOLD fMRI may be useful in early detection of diabetic neuropathy. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629995      PMCID: PMC2742673          DOI: 10.1002/jmri.21856

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  28 in total

1.  Correlation of functional activation in the rat spinal cord with neuronal activation detected by immunohistochemistry.

Authors:  Jane Lawrence; Patrick W Stroman; Saro Bascaramurty; Larry M Jordan; Krisztina L Malisza
Journal:  Neuroimage       Date:  2004-08       Impact factor: 6.556

2.  GDNF rescues nonpeptidergic unmyelinated primary afferents in streptozotocin-treated diabetic mice.

Authors:  S K Akkina; C L Patterson; D E Wright
Journal:  Exp Neurol       Date:  2001-01       Impact factor: 5.330

3.  Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties.

Authors:  A Pertovaara; H Wei; J Kalmari; M Ruotsalainen
Journal:  Exp Neurol       Date:  2001-02       Impact factor: 5.330

4.  Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor.

Authors:  G S Bennett; N E Garrett; L T Diemel; S D Brain; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

5.  Functional MRI of the rat lumbar spinal cord involving painful stimulation and the effect of peripheral joint mobilization.

Authors:  Krisztina L Malisza; Patrick W Stroman; Allan Turner; Lori Gregorash; Tadeusz Foniok; Anthony Wright
Journal:  J Magn Reson Imaging       Date:  2003-08       Impact factor: 4.813

6.  Erythropoietin both protects from and reverses experimental diabetic neuropathy.

Authors:  Roberto Bianchi; Belgin Buyukakilli; Michael Brines; Costanza Savino; Guido Cavaletti; Norberto Oggioni; Giuseppe Lauria; Monica Borgna; Raffaella Lombardi; Burak Cimen; Ulku Comelekoglu; Arzu Kanik; Cengiz Tataroglu; Anthony Cerami; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

7.  Deficient axonal transport of substance P in streptozocin-induced diabetic rats. Effects of sorbinil and insulin.

Authors:  D R Tomlinson; J P Robinson; G B Willars; P Keen
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

8.  Increased responsiveness of sensory neurons in the saphenous nerve of the streptozotocin-diabetic rat.

Authors:  S C Ahlgren; D M White; J D Levine
Journal:  J Neurophysiol       Date:  1992-12       Impact factor: 2.714

9.  Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor.

Authors:  L T Diemel; W J Brewster; P Fernyhough; D R Tomlinson
Journal:  Brain Res Mol Brain Res       Date:  1994-01

10.  Altered temporal pattern of mechanically evoked C-fiber activity in a model of diabetic neuropathy in the rat.

Authors:  X Chen; J D Levine
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  6 in total

1.  Diabetes induces changes in ILK, PINCH and components of related pathways in the spinal cord of rats.

Authors:  Y Jiang; A P Mizisin; A Rearden; C G Jolivalt
Journal:  Brain Res       Date:  2010-03-27       Impact factor: 3.252

2.  CNS animal fMRI in pain and analgesia.

Authors:  David Borsook; Lino Becerra
Journal:  Neurosci Biobehav Rev       Date:  2010-11-30       Impact factor: 8.989

3.  Resting-state functional connectivity in the rat cervical spinal cord at 9.4 T.

Authors:  Tung-Lin Wu; Feng Wang; Arabinda Mishra; George H Wilson; Nellie Byun; Li Min Chen; John C Gore
Journal:  Magn Reson Med       Date:  2017-09-14       Impact factor: 4.668

Review 4.  Ten Key Insights into the Use of Spinal Cord fMRI.

Authors:  Jocelyn M Powers; Gabriela Ioachim; Patrick W Stroman
Journal:  Brain Sci       Date:  2018-09-10

5.  Large-scale functional ultrasound imaging of the spinal cord reveals in-depth spatiotemporal responses of spinal nociceptive circuits in both normal and inflammatory states.

Authors:  Julien Claron; Vincent Hingot; Isabelle Rivals; Line Rahal; Olivier Couture; Thomas Deffieux; Mickael Tanter; Sophie Pezet
Journal:  Pain       Date:  2021-04-01       Impact factor: 7.926

6.  Proteomics Analysis of the Spinal Dorsal Horn in Diabetic Painful Neuropathy Rats With Electroacupuncture Treatment.

Authors:  Xiangmei Yu; Xiaomei Chen; Weiting Liu; Menghong Jiang; Zhifu Wang; Jing Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.